Jove
Visualize
联系我们

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

86
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
86

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Diagnostic impact of interpretation criteria for [<sup>18</sup>F]PSMA-1007 PET/CT: Prospective comparison with CT and bone scan.

European journal of nuclear medicine and molecular imaging·2026
Same author

Characterization and first application of a new <sup>236</sup>Np spike for (A)MS measurements of <sup>237</sup>Np.

Talanta·2026
Same author

Tellurium-118 as a novel radionuclide for long-term positron emission tomography.

Scientific reports·2026
Same author

Breaking the Immiscibility Barrier: A Mechanochemical Approach to Enable the Direct Glycosylation of Native Sugars with Hydrophobic Aliphatic Alcohols.

Journal of the American Chemical Society·2026
Same author

Flavonoid Interactions with Renal Organic Anion Transporters OAT1 and OAT3: Structure-Activity Relationships and Clinical Implications.

International journal of molecular sciences·2026
Same author

Enhanced tumor retention of the novel LAT1-targeting PET probe [<sup>18</sup>F]FAMT-OMe: A comparative study with [<sup>18</sup>F]FAMT in glioma mouse models.

Nuclear medicine and biology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 6, 2025

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.6K

开发LAT1-选择性核医学疗法使用阿斯-21111的治疗方法.

Kazuko Kaneda-Nakashima1,2, Yoshifumi Shirakami2, Kentaro Hisada1

  • 1Radiation Biological Chemistry, MS-CORE, FRC, Graduate School of Science, Osaka University, 1-1 Machikaneyama-cho, Toyonaka, Osaka 560-0043, Japan.

International journal of molecular sciences
|November 27, 2024
PubMed
概括

研究人员开发了一种针对L型氨基酸载体1 (LAT1) 的新型核医学治疗方法. 这种利用astatine-211的新化合物显示了对LAT1向治疗的增强保留和优越的治疗效果.

关键词:
在LAT1中使用LAT1.氨基酸氨基酸是一种氨基酸.一个statine-21111是什么癌症治疗疗法 癌症治疗核医学是核医学的一种.

更多相关视频

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
09:08

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

1.3K
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.7K

相关实验视频

Last Updated: Jun 6, 2025

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.6K
Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
09:08

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

1.3K
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.7K

科学领域:

  • 核医学是一种核医学.
  • 放射性药物化学 放射性药物化学
  • 分子成像和分子疗法

背景情况:

  • L型氨基酸载体1 (LAT1) 是癌症治疗的关键标.
  • 之前开发的以astatine-211 (211At) 为基础的针对LAT1的治疗方法显示出有前途.
  • 放射性标记和化合物结构的优化对于治疗疗效至关重要.

研究的目的:

  • 开发一种改进的核医学治疗剂,针对LAT1.1.
  • 为了增强211At标记的LAT1向化合物的保留和治疗效果.
  • 为了确定最佳的结构修改,以改善放射性药物特性.

主要方法:

  • 基于3-阿斯塔甲基-L-氨酸的新型211At标记化合物的合成和评估.
  • 通过修改类组来研究结构保持关系.
  • 对不同异构体和同类物的吸收动力学和生物分布进行比较分析.
  • 在临床前模型中评估治疗疗效.

主要成果:

  • 将醇基组修改为甲基组显著增加了化合物保留.
  • 与D-异构体相比,L-异构体的吸收率更高.
  • 用乙基或基取代甲基组并没有改善保留,导致非特异性积累增加.
  • 一个简化的结构,211At-AAMT-O-Me-L,表现出更快的吸收和有利的特性.

结论:

  • 结构修改,特别是基的甲基化,对于增强211At标记的LAT1向放射性药物的保留至关重要.
  • 开发的化合物211At-AAMT-O-Me-L在易于标记,高特异性放射性,稳定性和强大的治疗效果方面具有优势.
  • 这种优化的放射性药物代表了针对LAT1表达性疾病的向核医学疗法的有希望的进步.